BioGend Therapeutics Co., Ltd. (TPEX:6733)
36.65
+0.15 (0.41%)
At close: Feb 11, 2026
7.01% (1Y)
| Market Cap | 4.56B +11.1% |
| Revenue (ttm) | 212.43M +35.6% |
| Net Income | -102.59M |
| EPS | -0.83 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 122,669 |
| Average Volume | 223,356 |
| Open | 36.40 |
| Previous Close | 36.50 |
| Day's Range | 36.35 - 37.00 |
| 52-Week Range | 23.20 - 49.15 |
| Beta | 0.19 |
| RSI | 42.39 |
| Earnings Date | Feb 26, 2026 |